Skip to main content
Equibles
CMPS logo

CMPS · COMPASS Pathways plc · Earnings Call Transcripts & Audio

Track CMPS — free

Use CMPS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CMPS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$14.35 +0.13 (+0.91%) At close · Sep 11
Rebalance outlook locked
Market Cap
$1.99B
Shares
138.48M

COMPASS Pathways plc Earnings Call Transcripts

Quarterly earnings calls for COMPASS Pathways plc (CMPS), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.

Pull transcripts and briefs through the earnings call transcript API or MCP →
Conference
Investor event
2026-09-16
COMPASS Pathways plc (CMPS) September 2026 Conference
Scheduled
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-09-15
COMPASS Pathways plc (CMPS) September 2026 Conference
Scheduled
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-08-12
COMPASS Pathways plc (CMPS) August 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q2
2026-08-05
COMPASS Pathways plc (CMPS) Q2 2026 Earnings Call Transcript
Confident tone Treatment Site Infrastructure Commercial Readiness & Launch Planning Phase 3 Data & De-risking
Diluted EPS
$-1.88
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-05-13
COMPASS Pathways plc (CMPS) Q1 2026 Earnings Call Transcript
Confident tone TRD Phase III data and NDA submission REMS and patient safety framework PTSD program expansion
Diluted EPS
$-0.30
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q3
2025-11-04
COMPASS Pathways plc (CMPS) Q3 2025 Earnings Call Transcript
Confident tone FDA regulatory progress and NDA filing SPRAVATO infrastructure and site readiness COMP360 commercial launch readiness
Diluted EPS
$-1.44
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-07-31
COMPASS Pathways plc (CMPS) Q2 2025 Earnings Call Transcript
Confident tone FDA engagement and regulatory path Commercial preparation and launch readiness Phase 3 trial results in TRD
Diluted EPS
$-0.41
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-08
COMPASS Pathways plc (CMPS) Q1 2025 Earnings Call Transcript
Confident tone COMP360 durability / long-term data Treatment-resistant depression unmet need Commercial preparation and strategic collaborations
Diluted EPS
$-0.24
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-27
COMPASS Pathways plc (CMPS) Q4 2024 Earnings Call Transcript
Confident tone PTSD program DSMB safety review Phase 3 006 trial
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-10-31
COMPASS Pathways plc (CMPS) Q3 2024 Earnings Call Transcript
Cautious tone Commercial preparation and launch readiness Trial complexity and site management COMP005 Phase III timing and delays
Diluted EPS
$-0.56
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-01
COMPASS Pathways plc (CMPS) Q2 2024 Earnings Call Transcript
Positive tone Phase 3 TRD program (005 and 006 trials) Lykos AdCom insights and FDA considerations PTSD and MDD exploratory programs
Diluted EPS
$-0.56
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-08
COMPASS Pathways plc (CMPS) Q1 2024 Earnings Call Transcript
Positive tone Phase II PTSD data Phase III COMP360 TRD trials Safety and tolerability
Diluted EPS
$-0.55
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-02-29
COMPASS Pathways plc (CMPS) Q4 2023 Earnings Call Transcript
Positive tone Phase III TRD program Anxiety opportunity PTSD expansion
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-02
COMPASS Pathways plc (CMPS) Q3 2023 Earnings Call Transcript
Diluted EPS
$-0.67
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-03
COMPASS Pathways plc (CMPS) Q2 2023 Earnings Call Transcript
Diluted EPS
$-620.00
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-11
COMPASS Pathways plc (CMPS) Q1 2023 Earnings Call Transcript
Diluted EPS
$-0.57
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-02-28
COMPASS Pathways plc (CMPS) Q4 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-03
COMPASS Pathways plc (CMPS) Q3 2022 Earnings Call Transcript
Diluted EPS
$-0.43
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-02-24
COMPASS Pathways plc (CMPS) Q4 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Showing 1–19 of 19 earnings calls
Key facts CIK 1816590 CUSIP 20451W101 13F (30d) 98 filings 96 filers Visit website Investor relations